Clinical Trial: Acetazolamide in Persons With Type 1 Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Type 1 Diabetes
Study Type: INTERVENTIONAL
Official Title: Acetazolamide and Tubuloglomerular Feedback in Persons With Type 1 Diabetes: A Clinical Trial
Brief Summary:
This is a dose finding trial where participants will receive escalating doses of acetazolamide, each for a 2-week dosing period followed by a 2-week washout period.The three doses examined will be open-label 62.5mg twice daily, 125mg twice daily, and 250mg twice daily of acetazolamide.A baseline Iohexol GFR (glomerular filtration rate) measurement will be performed prior to the first administration of each acetazolamide dose and then again following each dosing period.Including a screening visit and a follow-up…
Read more